How APoB levels may change the way we predict CHD
Study suggests measuring the levels may be superior to testing for cholesterol
11th February 2019
By Clare Pain
Levels of apolipoprotein B (APoB) may be a better predictor of coronary heart disease risk than either low-density lipoprotein cholesterol (LDL-C) or triglyceride levels, an international study suggests.
The research also helps clarify the long-debated role of triglycerides in atherosclerosis.
Commentators suggest that the UK study findings – drawing on DNA data from more than 600,000 people in 63 studies – might change the tests doctors rely on to establish CHD risk.
The results provide some of the first evidence that the very
